ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 86 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $35,075,000 | -22.6% | 1,859,760 | -51.7% | 0.01% | -23.1% |
| Q2 2019 | $45,307,000 | +0.9% | 3,849,394 | +17.0% | 0.01% | -7.1% |
| Q1 2019 | $44,899,000 | +58.6% | 3,289,275 | +19.1% | 0.01% | +55.6% |
| Q4 2018 | $28,312,000 | +42.9% | 2,762,172 | +132.2% | 0.01% | +80.0% |
| Q3 2018 | $19,810,000 | -4.1% | 1,189,776 | -9.0% | 0.01% | -16.7% |
| Q2 2018 | $20,659,000 | -4.0% | 1,307,520 | -22.9% | 0.01% | 0.0% |
| Q1 2018 | $21,528,000 | +13.1% | 1,695,087 | +2.0% | 0.01% | +20.0% |
| Q4 2017 | $19,030,000 | +2.4% | 1,661,997 | +9.6% | 0.01% | 0.0% |
| Q3 2017 | $18,577,000 | +125.8% | 1,516,494 | +111.1% | 0.01% | +150.0% |
| Q2 2017 | $8,226,000 | -40.9% | 718,389 | +7.4% | 0.00% | -50.0% |
| Q1 2017 | $13,917,000 | -1.3% | 669,085 | -1.3% | 0.00% | 0.0% |
| Q4 2016 | $14,106,000 | -56.3% | 678,180 | -31.2% | 0.00% | -60.0% |
| Q3 2016 | $32,286,000 | -2.0% | 985,207 | -25.3% | 0.01% | -9.1% |
| Q2 2016 | $32,929,000 | +136.8% | 1,318,757 | +132.3% | 0.01% | +175.0% |
| Q1 2016 | $13,907,000 | -25.1% | 567,804 | +1.0% | 0.00% | -33.3% |
| Q4 2015 | $18,566,000 | +48.7% | 562,102 | +47.5% | 0.01% | +50.0% |
| Q3 2015 | $12,483,000 | -25.7% | 381,026 | +20.1% | 0.00% | -20.0% |
| Q2 2015 | $16,811,000 | +55.5% | 317,373 | -15.3% | 0.01% | +66.7% |
| Q1 2015 | $10,813,000 | +75.1% | 374,695 | +76.5% | 0.00% | +50.0% |
| Q4 2014 | $6,177,000 | – | 212,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |